GNI Group Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GNI Group Limited with three other
companies in this sector in Japan:
Japan Tissue Engineering Company Limited
sales of 2.14 billion Japanese Yen [US$20.09 million]
of which 96%
was Regenerative Medicine Products Business),
Trans Genic Inc
(2.30 billion Japanese Yen [US$21.67 million]
of which 50%
was CRO Business), and
Medical Data Vision Co Ltd
(3.23 billion Japanese Yen [US$30.36 million]
GNI Group Limited reported sales of ¥2.65 billion (US$24.92 million)
December of 2017.
increase of 102.6%
versus 2016, when the company's sales were ¥1.31 billion.
Sales at GNI Group Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 1,535%).